Literature DB >> 16097155

[Artificial urinary sphincters in women: indications, techniques, results].

Morgan Roupret1, Emmanuel Chartier-Kastler, François Richard.   

Abstract

Artificial urinary sphincter (AUS) is one of the last resort surgical treatments proposed to patients with stress urinary incontinence (SUI) due to severe sphincter incompetence. Despite convincing functional results, AUS implantation in women is a preferred treatment option only for certain teams. An abdominal approach for implantation of the prosthesis is often preferred to the transvaginal approach. The most recent data show that more than 84% of patients are continent at 5 years. The 5-year sphincter revision rate is about 20%. In 2005, AUS is still a valid treatment option in SUI and has a real place in the urologist's therapeutic armamentarium even in the age of synthetic suburethral tape.

Entities:  

Mesh:

Year:  2005        PMID: 16097155

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  3 in total

1.  Is the implantation of an artificial urinary sphincter with a large cuff in women with severe urinary incontinence associated with worse perioperative complications and functional outcomes than usual?

Authors:  Aurélie Revaux; Morgan Rouprêt; Elise Seringe; Vincent Misraï; Florence Cour; Emmanuel Chartier-Kastler
Journal:  Int Urogynecol J       Date:  2011-04-29       Impact factor: 2.894

Review 2.  A systematic review and meta-analysis of clinical and functional outcomes of artificial urinary sphincter implantation in women with stress urinary incontinence.

Authors:  Bara Barakat; Knut Franke; Sameh Hijazi; Samer Schakaki; Ulrich Gauger; Viktoria Hasselhof; Thomas-Alexander Vögeli
Journal:  Arab J Urol       Date:  2020-02-04

Review 3.  A systematic review of the treatment for female stress urinary incontinence by ACT® balloon placement (Uromedica, Irvine, CA, USA).

Authors:  Véronique Phé; Kien Nguyen; Morgan Rouprêt; Vincent Cardot; Jérôme Parra; Emmanuel Chartier-Kastler
Journal:  World J Urol       Date:  2013-06-20       Impact factor: 4.226

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.